Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth. The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications The global Benign Prostatic Hyperplasia Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Benign Prostatic Hyperplasia Devices market based on company, product type, end user and key regions. This report studies the global market size of Benign Prostatic Hyperplasia Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Benign Prostatic Hyperplasia Devices in these regions. This research report categorizes the global Benign Prostatic Hyperplasia Devices market by top players/brands, region, type and end user. This report also studies the global Benign Prostatic Hyperplasia Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Lumenis Olympus corporation Urologix Boston Scientific corporation Lisa Laser Medifocus Neotrac ProArc Medical LTD Urotech GMBH Market size by Product Transurethral Resection of the Prostate (TURP) Transurethral Microwave Therapy (TUMT) Transurethral Needle Ablation of the Prostate (TUNA) Laser Surgery Prostatic Stenting Others Market size by End User Hospitals and Clinics Ambulatory Surgical Centers(ASC) Home Others Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Benign Prostatic Hyperplasia Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Benign Prostatic Hyperplasia Devices market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Benign Prostatic Hyperplasia Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Benign Prostatic Hyperplasia Devices submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia Devices are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Benign Prostatic Hyperplasia Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Benign Prostatic Hyperplasia Devices Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Product 1.4.2 Transurethral Resection of the Prostate (TURP) 1.4.3 Transurethral Microwave Therapy (TUMT) 1.4.
